These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS). Neuhaus KL, von Essen R, Tebbe U, Vogt A, Roth M, Riess M, Niederer W, Forycki F, Wirtzfeld A, Maeurer W. J Am Coll Cardiol; 1992 Apr; 19(5):885-91. PubMed ID: 1552106 [Abstract] [Full Text] [Related]
5. New developments in thrombolytic therapy. Collen D, Gold HK. Adv Exp Med Biol; 1990 Apr; 281():333-54. PubMed ID: 2129372 [Abstract] [Full Text] [Related]
6. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. Lundergan CF, Reiner JS, McCarthy WF, Coyne KS, Califf RM, Ross AM. J Am Coll Cardiol; 1998 Sep; 32(3):641-7. PubMed ID: 9741505 [Abstract] [Full Text] [Related]
7. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W, Schmutzler H. Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [Abstract] [Full Text] [Related]
8. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Simes RJ, Topol EJ, Holmes DR, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM. Circulation; 1995 Apr 01; 91(7):1923-8. PubMed ID: 7895348 [Abstract] [Full Text] [Related]
9. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. Baardman T, Hermens WT, Lenderink T, Molhoek GP, Grollier G, Pfisterer M, Simoons ML. Eur Heart J; 1996 Feb 01; 17(2):237-46. PubMed ID: 8732377 [Abstract] [Full Text] [Related]
10. New developments in thrombolytic therapy. Collen DC, Gold HK. Thromb Res Suppl; 1990 Feb 01; 10():105-31. PubMed ID: 2180114 [Abstract] [Full Text] [Related]
11. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Langer A, Krucoff MW, Klootwijk P, Veldkamp R, Simoons ML, Granger C, Califf RM, Armstrong PW. J Am Coll Cardiol; 1995 Jun 01; 25(7):1552-7. PubMed ID: 7759706 [Abstract] [Full Text] [Related]
13. [Thrombolytic drugs in acute myocardial infarct]. Ambrosioni E, Degli Esposti D. Cardiologia; 1991 Dec 01; 36(12 Suppl 1):395-402. PubMed ID: 1841796 [Abstract] [Full Text] [Related]
14. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. Reiner JS, Lundergan CF, van den Brand M, Boland J, Thompson MA, Machecourt J, Py A, Pilcher GS, Fink CA, Burton JR. J Am Coll Cardiol; 1994 Nov 15; 24(6):1439-44. PubMed ID: 7930273 [Abstract] [Full Text] [Related]
15. [Different therapeutic regimens in thrombolysis of acute myocardial infarct]. Zeymer U, Neuhaus KL. Z Kardiol; 1994 Nov 15; 83 Suppl 6():83-8. PubMed ID: 7863705 [Abstract] [Full Text] [Related]
16. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group. Zeymer U, Tebbe U, Essen Rv, Haarmann W, Neuhaus KL. Am Heart J; 1999 Jan 15; 137(1):34-8. PubMed ID: 9878934 [Abstract] [Full Text] [Related]
18. [Arterial permeability, objective of thrombolytic therapy]. Bassand JP, Schiele F, Bernard Y, Anguenot T. Arch Mal Coeur Vaiss; 1992 May 15; 85(5 Suppl):677-87. PubMed ID: 1530409 [Abstract] [Full Text] [Related]
19. Comparative effects of APSAC and rt-PA on infarct size and left ventricular function in acute myocardial infarction. A multicenter randomized study. Bassand JP, Cassagnes J, Machecourt J, Lusson JR, Anguenot T, Wolf JE, Maublant J, Bertrand B, Schiele F. Circulation; 1991 Sep 15; 84(3):1107-17. PubMed ID: 1909218 [Abstract] [Full Text] [Related]
20. A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group. Grines CL, Nissen SE, Booth DC, Branco MC, Gurley JC, Bennett KA, DeMaria AN. J Am Coll Cardiol; 1989 Sep 15; 14(3):573-80. PubMed ID: 2504797 [Abstract] [Full Text] [Related] Page: [Next] [New Search]